Advertisement
Australia markets close in 1 hour 23 minutes
  • ALL ORDS

    7,851.40
    -86.10 (-1.08%)
     
  • ASX 200

    7,589.90
    -93.10 (-1.21%)
     
  • AUD/USD

    0.6528
    +0.0005 (+0.07%)
     
  • OIL

    83.87
    +0.30 (+0.36%)
     
  • GOLD

    2,347.30
    +4.80 (+0.20%)
     
  • Bitcoin AUD

    98,516.84
    -2.80 (-0.00%)
     
  • CMC Crypto 200

    1,387.67
    +5.09 (+0.37%)
     
  • AUD/EUR

    0.6086
    +0.0013 (+0.21%)
     
  • AUD/NZD

    1.0958
    +0.0000 (+0.00%)
     
  • NZX 50

    11,813.59
    -132.84 (-1.11%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,626.75
    +342.21 (+1.98%)
     
  • NIKKEI 225

    38,022.60
    +394.12 (+1.05%)
     

Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?

Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?

One welcome sign with the COVID-19 pandemic is how many companies, both large and small, have scrambled to develop diagnostic tests, antiviral treatments, and vaccines. Sure, these companies are in business to make money and have a profit motive behind their efforts. Inovio Pharmaceuticals (NASDAQ: INO) ranks as one of the leaders in the race to develop a COVID-19 vaccine.